Find your fit
Compare compounds
Pick up to three compounds and see target, presentation, purity and Certificate of Analysis side by side.
Retatrutide vs Tirzepatide
Retatrutide 32

- Research area
- Weight-loss and metabolic research
- Receptor target
- Triple agonist — GLP-1 + GIP + glucagon receptors
- Presentation
- Pre-filled multi-dose pen · 2/4/8 mg dial
- Strength
- 32 mg
- HPLC purity
- 98.75%
- Certificate of Analysis
- Published — view batch report
- Studied alongside
- Tirzepatide
Back in stock soon
Tirzepatide 30

- Research area
- Weight-loss and metabolic research
- Receptor target
- Dual agonist — GLP-1 + GIP receptors
- Presentation
- Pre-filled multi-dose pen
- Strength
- 30 mg
- HPLC purity
- 99.29%
- Certificate of Analysis
- Published — view batch report
- Studied alongside
- Retatrutide
Supplied strictly for research and analytical purposes only. Not for human consumption, and not medical advice. Figures above describe the material as supplied — purity is taken from the published Certificate of Analysis for the current batch.
Brand comparisons
Body Pharm vs other brands
Honest, source-backed comparisons of the Body Pharm range against other UK research-peptide brands — format, strengths, Certificate of Analysis and shipping, side by side. For research and analytical purposes only.
Body Pharm Retatrutide vs Synedica Retatrutide: Pen Review
Retatrutide · Body Pharm vs Synedica
Body Pharm Retatrutide vs UK SARMs Retatrutide: Pen Review
Retatrutide · Body Pharm vs UK SARMs
Body Pharm Retatrutide vs Alluvi Retatrutide: Pen Review
Retatrutide · Body Pharm vs Alluvi
Body Pharm BPC-157 + TB-500 vs Alluvi: Pen Review
BPC-157 + TB-500 · Body Pharm vs Alluvi
Body Pharm NAD+ vs Alluvi NAD+: Pen Review
NAD+ · Body Pharm vs Alluvi
Body Pharm Tirzepatide vs Alluvi Tirzepatide: Pen Review
Tirzepatide · Body Pharm vs Alluvi